title: Modification of methodology results in improvement in simultaneous kidney-islet success.
authors.affiliation: Islet Transplant Center, Washington University School of Medicine, St Louis, MO 63110.
authors.forename: D C
authors.initials: DC
authors.lastname: Brennan
authors.forename: D W
authors.initials: DW
authors.lastname: Scharp
authors.forename: N H
authors.initials: NH
authors.lastname: White
authors.forename: K S
authors.initials: KS
authors.lastname: Flavin
authors.forename: J M
authors.initials: JM
authors.lastname: Zukosky
authors.forename: M F
authors.initials: MF
authors.lastname: Ansara
authors.forename: P E
authors.initials: PE
authors.lastname: Cryer
authors.forename: P E
authors.initials: PE
authors.lastname: Lacy
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002096:C-Peptide / Q000097:blood; D002478:Cells, Cultured; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007515:Islets of Langerhans; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000379:methods* / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D014021:Tissue Preservation; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D002096:C-Peptide; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone